Article info
PDFViewpoint
Immunomodulatory therapy in dengue: need for clinical trials and evidence base
- Correspondence to Professor A V Ramanan, Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol BS6 6BT, UK; a.ramanan{at}bristol.ac.uk
Citation
Immunomodulatory therapy in dengue: need for clinical trials and evidence base
Publication history
- Received March 5, 2022
- Accepted May 17, 2022
- First published June 9, 2022.
Online issue publication
June 13, 2023
Article Versions
- Previous version (18 May 2023).
- Previous version (18 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.